Pharmabiz2h
Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD
Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD: Our Bureau, New Delhi Saturday, ...
Pharmabiz14m
‘Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025
Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025: Basel Saturday, April 5, 2025, 10:00 Hrs [IST] Roche announced that new data were p ...
Pharmabiz2h
Indian healthcare sees urgent need for skill development to offset shortfall of doctors, nurses and paramedics
Nandita Vijayasimha, Bengaluru Saturday, April 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
WB DCA files police complaint against threatening calls to DIs to stop inspections at sale premises & supply chains
WB DCA files police complaint against threatening calls to DIs to stop inspections at sale premises & supply chains: Peethaambaran Kunnathoor, Chennai Saturday, April 5, 2025, 08: ...
Pharmabiz2h
Ayush ministry needs to come up with new schemes and strategies to achieve targets: Parliamentary Panel
Gireesh Babu, New Delhi Saturday, April 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Indian pharma poised to enhance affordability & accessibility of CAR-T cell therapy to combat cancer
Indian pharma poised to enhance affordability & accessibility of CAR-T cell therapy to combat cancer: Shardul Nautiyal, Mumbai Saturday, April 5, 2025, 08:00 Hrs [IST] The Indian ...
Pharmabiz17h
Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi
Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi: Our Bureau, Mumbai Friday, April 4, ...
Pharmabiz16h
The Good Bug presents clinically proven natural GLP-1 weight loss solution amid rising obesity rates in India
The Good Bug presents clinically proven natural GLP-1 weight loss solution amid rising obesity rates in India: Our Bureau, Bengaluru Friday, April 4, 2025, 17:20 Hrs [IST] The Goo ...
Pharmabiz20h
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...
Pharmabiz18h
Vividion Therapeutics doses first patient in phase I study of RAS-PI3Ka inhibitor to treat advanced solid tumours
San Diego, California Friday, April 4, 2025, 16:00 Hrs [IST] ...
Pharmabiz19h
Abbott introduces next-generation delivery system to streamline electrode placement during dorsal root ganglion stimulator implantations
Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...
Pharmabiz16h
Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources
Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources: Dublin, Ireland Friday, April 4, 2025, 18:00 Hrs [IST] Biologit, a spec ...